GAMMA Investing’s Olema Pharmaceuticals OLMA Stock Holding History

GAMMA Investing’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.46K	Buy	596 +8	+1%	+$107	﹤0.01%	3327
2026 Q1	$8.77K	Sell	588 -135	-19%	-$3K	﹤0.01%	3136
2025 Q4	$18.1K	Buy	723 +492	+213%	+$8.76K	﹤0.01%	2670
2025 Q3	$2.26K	Buy	+231	New	+$1.39K	﹤0.01%	3421
2025 Q1	–	Sell	-321	Closed	-$1.87K	–	3860
2024 Q4	$1.87K	Buy	321 +58	+22%	+$579	﹤0.01%	3239
2024 Q3	$3.14K	Buy	263 +207	+370%	+$2.65K	﹤0.01%	2920
2024 Q2	$606	Buy	56 +42	+300%	+$455	﹤0.01%	3168
2024 Q1	$158	Buy	+14	New	+$181	﹤0.01%	3255

Other funds holding OLMA

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

WWM

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

AFC

Ares Financial Consulting Calabasas, California $139M AUM

GAMMA Investing's OLMA Position: Q2 2026 in Review

GAMMA Investing increased its Olema Pharmaceuticals (OLMA) stake by 1.4% in Q2 2026, buying an estimated $107 and bringing the position to 596 shares worth $7.46K. The position accounts for ﹤0.01% of the portfolio, ranked #3327.

GAMMA Investing first reported a position in OLMA in Q1 2024 and has held it in 8 quarters since. The position peaked at $18.1K in Q4 2025. 10 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

GAMMA Investing held 596 shares of Olema Pharmaceuticals worth $7.46K as of Q2 2026.
GAMMA Investing bought 8 Olema Pharmaceuticals shares in Q2 2026, an estimated $107.
Olema Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3327 holding.
GAMMA Investing first reported a position in Olema Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
GAMMA Investing's Olema Pharmaceuticals position peaked at $18.1K in Q4 2025.
10 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.